Analysis of the TCGA-CHOL dataset, accessed through the UCSC Xena platform, demonstrated that CCA patients had significantly higher mRNA expression of ALPP and lower expression of ALPL, when compared to normal controls, among various alkaline phosphatase (ALP) isoenzymes (Figure 2A). This evidence concerns the gene ALPP and cholangiocarcinoma.